전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
adenocarcinoma
adenokartsinoom
마지막 업데이트: 2017-04-26
사용 빈도: 8
품질:
non-adenocarcinoma
mitte-adenokartsinoom
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
gastric adenocarcinoma
mao adenokartsinoom
마지막 업데이트: 2017-04-26
사용 빈도: 7
품질:
adenocarcinoma (n = 847)
adenokartsinoom (n = 847)
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
non-adenocarcinoma female
adenokartsinoom mitteadenokartsinoom naine
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
dose adjustments during treatment of pancreatic adenocarcinoma
annuse kohandamine pankrease adenokartsinoomi ravi käigus
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
the vast majority of patients had adenocarcinoma (92.1%).
valdaval enamikul esines adenokartsinoom (92,1%).
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
efficacy of docetaxel in the treatment of patients with gastric adenocarcinoma
dotsetakseeli efektiivsus mao adenokartsinoomi ravis
마지막 업데이트: 2017-04-26
사용 빈도: 7
품질:
table 1: dose level reductions for patients with pancreatic adenocarcinoma
tabel 1: annuse taseme vähendamine pankrease adenokartsinoomiga patsientidel
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
gastric cancer and gastro-oesophageal junction (gej) adenocarcinoma
maovähk või gastroösofageaal-liidese adenokartsinoom
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
(5) progression of pre-existing pancreatic adenocarcinoma with kras mutation.
(5) olemasoleva kras mutatsiooniga pankrease adenokartsinoomi progresseerumine.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
chronic myelomonocytic leukaemia(2)(4), pancreatic adenocarcinoma(5)
krooniline müelomonotsütaarne leukeemia(2)(4), pankrease adenokartsinoom(5)
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
in metastatic adenocarcinoma of the pancreas, abraxane was shown to improve overall survival.
pankrease metastaatilise adenokartsinoomiga patsientidel suurendas abraxane üldist elulemust.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
29 adenocarcinoma of the gastroesophageal junction, who had not received prior chemotherapy for metastatic disease.
dotsetakseeli efektiivsust ja ohutust metastaatilise mao adenokartsinoomi, sh gastroösofageaalliidese adenokartsinoomi ravis patsientidel, kes ei olnud varem saanud kemoteraapiat metastaatilise haiguse raviks, hinnati paljukeskuselises avatud randomiseeritud uuringus.
마지막 업데이트: 2011-10-23
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
docetaxel 75 mg/m² in combination with cisplatin and 5-fluorouracil for gastric adenocarcinoma cancer
dotsetakseel 75 mg/m2, kombinatsioonis tsisplatiini ja 5-fluorouratsiiliga mao adenokartsinoomi raviks
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
20 taxotere 75 mg/ m² in combination with cisplatin and 5-fluorouracil for gastric adenocarcinoma cancer
20 taxotere 75 mg/ m2 kombinatsioonis tsisplatiini ja 5– fluorouratsiiliga mao adenokartsinoomi raviks:
마지막 업데이트: 2012-04-11
사용 빈도: 4
품질:
20 docetaxel winthrop 75 mg/ m² in combination with cisplatin and 5-fluorouracil for gastric adenocarcinoma cancer
20 docetaxel winthrop 75 mg/ m2 kombinatsioonis tsisplatiini ja 5– fluorouratsiiliga mao adenokartsinoomi raviks:
마지막 업데이트: 2012-04-11
사용 빈도: 4
품질:
5.8 % of the adenocarcinoma patients entered the study with locally recurrent disease stage as had been evaluated at baseline.
5,8% adenokartsinoomiga patsientidest kaasati uuringusse uuringu alguses määratud paikselt retsidiveerunud haiguse staadiumis.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
description of selected adverse reactions in gastric adenocarcinoma cancer for docetaxel 75 mg/m2 in combination with cisplatin and 5-fluorouracil
kõrvaltoimete valikuline kirjeldus mao adenokartsinoomi kombinatsioonravi korral dotsetakseeliga annuses 75 mg/ m² ning tsisplatiini ja 5-fluorouratsiiliga
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
diarrhoea occurred in 43.4 % (≥ grade 3: 6.3 %) of adenocarcinoma patients in the nintedanib arm.
kõhulahtisus esines nintedaniibi rühmas 43,4% (≥ 3. astme kõhulahtisust 6,3%) adenokartsinoomiga patsientidest.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질: